SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Protein Design Labs (PDLI): Stock strong
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
407 58 0 PDLI
Emcee:  Stanley Cowen Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
307In my view Tuck, you either treat and try to reverse the liver fibrosis, or you Biotech Jim-6/15/2006
306Yep it has orphan drug indication for the small population and also fast track ddr.praveen-6/15/2006
305Thanks. I had seen the indications and its survival rates, but did not know thetuck-6/15/2006
304Terlipressin addresses type 1 HRS, which comes at the end stage of liver diseasedr.praveen-6/15/2006
303I took a long position yesterday. Despite the PIER study, Lucentis will blow Matuck-6/15/2006
302Unfortunately, home is on the wrong side of the Atlantic for me. Dollar deprecinigel bates-5/15/2006
301I am not going on a vacation.I'll rather stay home n buy PDLI :-)dr.praveen-5/14/2006
300Starting to smell value. (Ignoring the incredible shrinking dollar...)nigel bates-5/14/2006
299They do have it at nothing for T. JonRobohogs-5/14/2006
298Thanks.kenhott-5/12/2006
297My notes say that: Somewhere they also have at least 4 potential approvals betwdr.praveen-5/12/2006
296Forbes article: forbes.com Cowen was quoted: "PDL's business faces skenhott-5/12/2006
295my understanding is 0; dont recall what the rate was; georgemopgcw-5/8/2006
294>>Our discounted cash flow analysis of the royalty stream suggests a potennigel bates-5/8/2006
293Citi: PDLI: Upgrading to Buy on Valuation BUY (1) Speculative (S) mopgcw-5/5/2006
292PDL BioPharma Business Update Friday, May 5, 2006 8:00 a.m. ET / 5:00 a.m. PT pkenhott-5/5/2006
291PDL BioPharma Announces First Quarter 2006 Financial Results Tuesday May 2, 4:05nigel bates-5/3/2006
290Zenapax in MS - Message 22303483nigel bates-3/28/2006
289PDL BioPharma Reports Patient Enrollment Completed for Terlipressin Phase 3 Clinnigel bates-3/23/2006
288PDL BioPharma Announces Fourth Quarter and Full Year 2005 Financial Results Mondnigel bates-2/28/2006
287Trellis Bioscience to Provide Cell Line Development Services to PDL BioPharma Usnigel bates-2/6/2006
286PDLI/HGSI <Also check PDL's new website at pdl.com > Human Genome Scdr.praveen-1/10/2006
285PDL Grants Patent Licenses to Merck for Humanized Antibodies Against Two Undisclnigel bates-1/3/2006
284Citigroup: PDLI: Raising FY05 Guid Again Given Upside on Royalty Rev & Pdt Smopgcw-12/11/2005
283Market seems keen... :-)nigel bates-9/6/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News